The Alzheimer disease-associated ␤-amyloid peptide has been shown to induce apoptotic neuronal death. In the present study, we test the hypothesis that the apoptotic pathway activated by ␤-amyloid is similar to the pathway activated by the Fas/TNFR family of death receptors, which requires caspase-8 activity and adaptor proteins such as FADD. We demonstrate that the selective caspase-8 inhibitor IETD-fmk blocks neuronal death induced by ␤-amyloid. Furthermore, using viral-mediated gene delivery, we show that neurons expressing dominant-negative FADD are protected from apoptosis induced by ␤-amyloid. Together these results indicate that the apoptotic pathway activated by ␤-amyloid requires both caspase-8 activity and FADD. These findings further support the hypothesis that ␤-amyloid might initiate apoptosis by cross-linking death receptors of the Fas/TNFR family.
INTRODUCTION
␤-Amyloid peptide (A␤) 2 accumulates in plaques in Alzheimer's disease (AD) brain. A␤ is toxic to cultured neurons (Barger et al., 1995; Pike et al., 1993) , and transgenic mice in which A␤ is overexpressed show behavioral deficits and pathology reminiscent of AD (Chen et al., 1998; Hsiao et al., 1996) . These findings have contributed to the prevailing view that A␤ deposition is important in the etiology of AD. Understanding how A␤ causes neuronal dysfunction and/or death, then, may be critical to clinical interventions to halt progression of the disease.
Neuronal death induced by A␤ displays characteristics of apoptosis, including plasma membrane blebbing, nuclear condensation, and DNA fragmentation (Loo et al., 1993) . Caspases, the effectors of apoptosis, are activated in neurons exposed to A␤ (Mattson et al., 1998) , and caspase inhibitors block A␤-induced cell death (Mattson et al., 1998) . Because A␤ must aggregate to be toxic to neurons (Pike et al., 1993) , we have suggested that A␤ might cross-link cell surface proteins to generate intracellular signaling leading to the activation of an apoptotic program, in a type of activation-induced programmed cell death (APCD) similar to that triggered by Fas ligand (FasL) (Cotman et al., 1996) .
Apoptosis induced by FasL involves aggregation of its receptor Fas (APO1/CD95) and recruitment of the Fas-associated death-domain-containing protein FADD (Schulze-Osthoff et al., 1998) . Procaspase-8, recruited to receptor complexes by binding to the death effector domain of FADD, undergoes proteolysis and activation. Active caspase-8 then initiates a cascade of caspase activation leading to cell death. Expression of a dominant negative FADD mutant (dnFADD) blocks FasLinduced apoptosis (Chinnaiyan et al., 1996b) . Similarly, FasL-induced apoptosis is blocked by the expression of the viral serpin crmA (Srinivasula et al., 1996; Tewari and Dixit, 1995) , a caspase inhibitor whose physiological target is likely to be caspase-8 (Zhou et al., 1997) . We have recently demonstrated that crmA expression
